The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors.
about
Early versus delayed postoperative radiotherapy for treatment of low-grade gliomasBiopsy versus resection for the management of low-grade gliomasBiopsy versus resection for the management of low-grade gliomasEarly versus delayed radiotherapy for the treatment of low-grade gliomasThe Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretationPsychotherapy Interventions for Managing Anxiety and Depressive Symptoms in Adult Brain Tumor Patients: A Scoping ReviewAssessing neurotoxicity from the low-dose radiation component of radiosurgery using magnetic resonance spectroscopy.Instruments for estimation of health-related quality of life in patients with skull base neoplasmsQuality-of-Life Assessment in Patients with Lesions of the Cranial Base.Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of lifeA pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost.Continuous daily sunitinib for recurrent glioblastoma.Psychosocial and neuropsychiatric aspects of patients with primary brain tumors.Quantitative assessment of cardiorespiratory fitness, skeletal muscle function, and body composition in adults with primary malignant glioma.Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma.Analysis of patient outcomes following proton radiation therapy for retinoblastoma.Reliability and Validity of the Korean Version of QOLIE-10 in Epilepsy.Assessment of clinical and nonclinical characteristics associated with health-related quality of life in patients with high-grade gliomas: a feasibility study.Development of the Japanese version of the Pediatric Quality of Life Inventory Brain Tumor ModuleThe validation of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30) in pre-operative patients with brain tumor in China.The Brain Symptom and Impact Questionnaire in brain metastases patients: a prospective long-term follow-up studyTBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.The James Supportive Care Screening: integrating science and practice to meet the NCCN guidelines for distress management at a Comprehensive Cancer CenterPalliative care and quality of life in neuro-oncology.Brain tumors in the older person.Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma.Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma.Quality of life as an outcome in clinical trials and cancer care: a primer for surgeons.Functional outcomes and quality of life in patients with brain tumours: a review of the literature.Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerationsBiopsy versus resection for the management of low-grade gliomas.Identifying the needs of brain tumor patients and their caregivers.Health-related quality of life and other clinical outcome assessments in brain tumor patients: challenges in the design, conduct and interpretation of clinical trials.Concordance of patient and caregiver reports in evaluating quality of life in patients with malignant gliomas and an assessment of caregiver burden.Feasibility and utility of telephone-based psychological support for people with brain tumor: a single-case experimental study.Quality of life in patients with stable disease after surgery, radiotherapy, and chemotherapy for malignant brain tumourChanges in functional performance measures in adults undergoing chemoradiation for primary malignant glioma: a feasibility study.Psychiatric symptoms in glioma patients: from diagnosis to management.Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice.Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients.
P2860
Q24186964-66D3CCDB-BDFE-40E2-A5F0-50CD2798227EQ24197750-8812E0F9-84A3-4E4E-B807-4D83FDC3776DQ24234687-E51550EB-039F-4BC7-A217-6C30B38EAACDQ24236013-B22F2D3C-BC57-4036-AD9C-A6AAFECEA716Q24807048-677B5695-2AC8-4204-8D51-D22F4A91385EQ26828353-FC846E5E-4AA9-4F18-806D-A2E99787966BQ30477377-6931AE37-12C2-4451-835A-533D4103B7FEQ30480848-BF787EF1-871D-4144-8C2F-E23252013E20Q30502452-D40BB474-5652-43EF-9B31-A55DFFB67816Q33270398-85088703-EF1E-41D5-A06E-737704C1D90CQ33378699-E3C3AD4C-133F-46C7-B017-73FB81BA5765Q33403947-27D151E8-E467-49EB-B245-1DDF32D685C6Q33606051-FFF4107E-260C-4A64-A3F8-9D2FBE684D5DQ33625236-5DC1324E-836F-4BEA-9F36-F19BD3E3D244Q33710967-845AD49D-A75A-416A-B4CE-AF9C67EC0F96Q33782262-1D9899E5-3B0B-47CE-A49F-29FEDA943708Q33790848-5CD02728-7B09-4B7E-8C0F-D80E2212A264Q33797398-B150D18A-BDA8-469D-9BB2-6D4545CAC599Q33864799-80E7C5B1-52C4-435F-BD03-2FEDACBDB752Q33879843-0A1CBCCE-A265-4F51-B747-8A22B9D9D541Q33913472-2BBB3966-CC0F-4E43-8418-4110E155C349Q33954557-0438968F-11A2-4374-89C8-C6AC5F0A478CQ33978339-B4B91A9D-6A24-48F4-99EA-85AB1BE225D6Q34019937-37E97E6C-3251-4AD2-B622-E3F764BEB4C0Q34087862-BDE37645-9C2D-42B7-BF5E-DC73A9E334B1Q34208293-966FE538-207B-42BB-BBCE-E3C36790568FQ34234748-D7A95B65-EC58-4043-A329-B03EC83C9B72Q34319606-944BBEB5-3C3C-42E9-9A33-091577C93487Q34397751-611B8F17-FA6A-4539-89EA-42199C745351Q34418437-E7076B43-2E84-4181-84A5-586BF31F7B68Q34555925-A7A47BDD-7857-4F54-92B0-762762B0AE02Q35205868-99DFD9EC-7AC2-4F50-966E-DBB4E61734FAQ35206236-FD583D60-5F17-4512-B6D7-A5A5BC1DA220Q35210747-1771B779-ED2B-4B6D-AFBF-24C2D910CF64Q35218832-48F7A626-5D6B-4C1F-9235-F58555FBDBD3Q35452804-425C6FF4-7C1D-46BE-8067-B6600DD26CCFQ35584120-56631B7C-0CB4-495A-97F6-80A3C10BDB91Q35743504-CCE9C111-7025-4160-B4DB-7D4F53C9FC2BQ35871611-FC9E28EE-2296-48F7-9D32-1800A5560802Q35880699-FD2ECF42-79ED-4807-B7CE-244E0BF41E77
P2860
The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
The Functional Assessment of C ...... nts with primary brain tumors.
@en
The Functional Assessment of Cancer Therapy
@nl
type
label
The Functional Assessment of C ...... nts with primary brain tumors.
@en
The Functional Assessment of Cancer Therapy
@nl
prefLabel
The Functional Assessment of C ...... nts with primary brain tumors.
@en
The Functional Assessment of Cancer Therapy
@nl
P2093
P1433
P1476
The Functional Assessment of C ...... nts with primary brain tumors.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(19950301)75:5<1151::AID-CNCR2820750515>3.0.CO;2-Q
P407
P577
1995-03-01T00:00:00Z